Openwater was founded in 2016 to explore an idea: What if advancements in fields as diverse as consumer electronics, semiconductor device physics, and artificial intelligence could come together for a future where the profound act of curing disease becomes a reality for all, transcending borders and transforming the course of human health. ​The world of healthcare diagnostics and therapeutics could be transformed the way that semiconductors and software have transformed everything else. This is no dream: 7 years into the journey of starting Openwater we now have strong clinical feasibility data that could lead to products which diagnose and treat a spectrum of diseases, from aggressive cancers to mental health disorders and debilitating strokes and beyond touching on treatments for COVID/long COVID, stimulating stem cells, and rejuvenation of senescent cells.